Rapid Therapeutic Science Laboratories, Inc.
RTSL
$0.0074
$0.000.00%
OTC PK
06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.20K | 17.60K | -- | -- | 112.20K |
Total Receivables | 82.50K | -- | -- | -- | -- |
Inventory | 175.00K | 175.00K | 175.00K | 175.00K | 175.00K |
Prepaid Expenses | 58.10K | 58.10K | 58.10K | 62.50K | 66.90K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 317.90K | 250.80K | 233.20K | 237.60K | 354.10K |
|
|||||
Total Current Assets | 317.90K | 250.80K | 233.20K | 237.60K | 354.10K |
Net Property, Plant & Equipment | 1.59M | 1.61M | 1.85M | 1.88M | 1.91M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 170.10K | 170.10K | 170.10K | 170.10K | 170.10K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 2.07M | 2.03M | 2.25M | 2.29M | 2.43M |
|
|||||
Total Accounts Payable | 670.00K | 634.80K | 891.40K | 547.80K | 394.20K |
Total Accrued Expenses | 173.90K | 148.90K | 124.70K | 102.80K | 81.00K |
Short-term Debt | 841.60K | 3.27M | 3.30M | 3.24M | 2.94M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.56M | 99.60K | 98.50K | 79.40K | 77.30K |
Total Finance Division Other Current Liabilities | 183.80K | 312.20K | 549.20K | 938.80K | 1.37M |
Total Other Current Liabilities | 183.80K | 312.20K | 549.20K | 938.80K | 1.37M |
Total Current Liabilities | 4.43M | 4.46M | 4.97M | 4.91M | 4.86M |
|
|||||
Total Current Liabilities | 4.43M | 4.46M | 4.97M | 4.91M | 4.86M |
Long-Term Debt | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
Short-term Debt | 841.60K | 3.27M | 3.30M | 3.24M | 2.94M |
Capital Leases | 237.90K | 259.20K | 280.20K | 318.10K | 338.50K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.81M | 4.87M | 5.40M | 5.37M | 5.35M |
|
|||||
Common Stock & APIC | 7.68M | 7.62M | 7.51M | 7.62M | 7.56M |
Retained Earnings | -10.08M | -10.12M | -10.32M | -10.37M | -10.14M |
Treasury Stock & Other | -337.30K | -337.30K | -337.30K | -337.30K | -337.30K |
Total Common Equity | -2.74M | -2.84M | -3.14M | -3.09M | -2.92M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.74M | -2.84M | -3.14M | -3.09M | -2.92M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.74M | -2.84M | -3.14M | -3.09M | -2.92M |
|